Rodrigo Machado-Vieira, MD, PhD, MSc

  • 8Articles
  • 46.3KReads
  • 2008–2024Active
  • 38Collaborators
  • 988Citations

About

Rodrigo Machado-Vieira, MD, PhD, MSc, is affiliated with the Department of Psychiatry and Behavioral Sciences at The University of Texas Health Science Center at Houston. Since 2008, Machado-Vieira has published extensively on major depressive disorder, bipolar disorder, and suicide, focusing on the rapid antidepressant and antisuicidal effects of ketamine and other N-methyl-D-aspartate antagonists. His work also explores clinical predictors of treatment response and the neurobiology underlying mood disorder switching.

Publications

JCP
Antisuicidal Effects of Ketamine in Patients With Comorbid AUD
Original Research

Antisuicidal Effects of Ketamine in Patients With Comorbid AUD

April 24, 2024

Intranasal ketamine induced rapid antidepressant effects versus placebo but did not significantly change suicidal ideation scores in patients with alcohol use disorder and suicidal ideation with past attempt.
, , , et al
JCP
Original Research

Sleep and Antisuicidal Response to Ketamine

December 6, 2016

Patients with insomnia and disrupted sleep are at increased risk of suicide. Check out this article to see if researchers found a link between antisuicidal response to ketamine and...
, , , et al
JCP
Original Research

Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression

May 15, 2014

, , , et al
JCP
Original Research

Rapid Resolution of Suicidal Ideation After a Single Infusion of an N-Methyl-d-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder

July 13, 2010

, , , et al
JCP
Original Research

The Neurobiology of the Switch Process in Bipolar Disorder: A Review

May 4, 2010

, , , et al
JCP
Original Research

Brain-Derived Neurotrophic Factor and Initial Antidepressant Response to an N-Methyl-d-Aspartate Antagonist

September 8, 2009

, , , et al
JCP
Original Research

A Double-Blind, Randomized, Placebo-Controlled 4-Week Study on the Efficacy and Safety of the Purinergic Agents Allopurinol and Dipyridamole Adjunctive to Lithium in Acute Bipolar Mania

August 31, 2008

, , , et al
JCP
Original Research

Rapid Onset of Antidepressant Action: A New Paradigm in the Research and Treatment of Major Depressive Disorder

June 30, 2008

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe